Insilico Medicine's official information positions it as a provider of generative AI and automation technologies for longevity and sustainability, and its Pharma.ai platform is a collection of generative AI software for drug discovery, scientific research, and sustainability. The Pharma.ai Q3 2026 platform update listed on the official website indicates that the platform is undergoing continuous iteration.
By use, the Pharma.ai platform covers multiple R&D stages, from target identification, molecule generation, molecule optimization, and preclinical evaluation to clinical trial design, as well as laboratory automation and data flow. The platform also includes foundation models for drug R&D and related evaluation benchmarks, used to measure model capabilities in the drug discovery and development process.
Main capabilities include: PandaOmics for discovering and prioritizing novel targets; Generative Biologics for discovering and optimizing novel biomolecules; Generative Chemistry for generating novel molecules; Alchemistry is a physics-based relative binding free energy engine; ADMET & Off-target provides instant optimization; Retrosynthesis for predicting synthetic routes for molecular structures; MDFlow provides end-to-end simulation workflows; MolSpace can visualize generation results with GTM and compare them with public data; Model Training supports training state-of-the-art models on data. In the clinical and experimental stages, inClinico is used to design and predict clinical trials, and Life Star 2 is an automated laboratory operations environment. DORA is a multi-agent generative research assistant, and Data Warehouse enables seamless cross-application data flow through efficient integration and standardization.
The platform also provides models and foundational capabilities: Nach01 is a multimodal natural language and chemical language foundation model; Science MMAI Gym is used to improve the intelligence of foundation models in drug discovery and development; Models provides frontier SOTA models for pharma; DDD Benchmark is used to evaluate model capabilities in the drug discovery and development process; ScienceAI Bench covers broader scientific reasoning in biology, chemistry, and longevity. Precious1GPT is used for multi-omics age prediction and target identification; Precious2GPT is used for multimodal multi-omics biological data synthesis; Precious3GPT is a multi-tissue, multi-species, multi-omics, multimodal life model; Virtual Aging Cell is a multi-agent virtual cell with biological age as its core condition. MCPs provides Model Context Protocol servers that expose Pharma.AI tools to agents; Skills + Agents provides agent workflows and reusable skills built on the Pharma.AI technology stack.
In addition, the official website mentions the Environmental Sustainability direction, namely generative AI technologies for environmental sustainability.
Usage: the official materials do not provide specific registration, pricing, deployment, or operating steps, so this is not yet available. Applicable scenarios: mainly for professional fields such as drug discovery, scientific research, longevity research, and environmental sustainability. Limitations: the official text does not explain information such as usage thresholds, data requirements, compliance, or available regions, so this is not yet available.